Against this backdrop, leading university researchers, supplement industry experts and investors gathered at the second annual Nutra Healthspan Summit in London last week to continue to shape the sector’s evolving definition of healthy aging. Rooted in the life extension movement, the concept began by shifting toward “living healthier for longer” to now feeling benefits in the day-to-day along the life curve with promises of a better tomorrow.
“The process of reframing longevity, probably under the umbrella of healthspan, is really important, and I think foundational to this is being able to communicate what vitality really feels like,” said Steve Jennings, co-founder of Jenerise, speaking during a session on cognitive health. “Longevity is something that’s very, very hard for people to wrap their heads around. It’s really difficult when you’re in an industry that is very much about prevention rather than cure to talk to people about longevity.”
From biological hallmarks to believable function
At last year’s summit, Lopez-Otin et al’s hallmarks of aging made prominent appearances across most presentations and panel discussions, with speakers working to distill the complexity of the body’s interdependent biological processes into measurable biomarkers tied to potential functional outcomes.
Commonly depicted by a wheel or circular diagram and first defined in a 2013 paper published in the journal Cell, the hallmarks are presented as slices and layers in a network of bidirectional influence and causal cascade. While these can be grouped into a hierarchical aging model of primary, antagonistic and integrative outcomes to trace the path towards mortality, this continues to raise questions as to how industry can best connect and translate science largely conducted in cell lines, microscopic nematodes and animal models into meaningful healthspan extension for consumers.
One session did focus on mitochondrial aging, featuring presentations by Phillipp Gut, adult health platform lead at Nestlé Research, and Colin Selman, head of school of molecular biosciences at University of Glasgow, who explored how mitochondrial health can be modified through molecular nutrition.

A key hallmark of aging, mitochondrial dysfunction occurs when the cells’ “powerhouses” become less efficient, producing less energy while accumulating oxidative stress. This decline can be accelerated by factors such as environmental pollution, micronutrient deficiencies, ultra-processed diets, UV radiation, chronic stress and poor sleep. Overtime, mitochondrial dysfunction then contributes to chronic inflammation and the development of age-related diseases, particularly those affecting energy-intensive organs.
Where Nestlé’s broader interest in nutritional approaches to healthy aging spans areas ranging from muscle recovery and microbiome research to plant-derived compounds that may mimic some effects of fasting, Gut emphasized the importance of understanding the underlying mechanisms to translate promising healthy longevity research trials into human applications. Early biological findings offer valuable insights, but carefully designed human studies remain essential to determining whether these approaches deliver meaningful benefits.
“I think it’s absolutely key, that there’s a strong understanding of the mechanism, because it will help you to derisk your clinical trial approach,” he said. “It will help you to ask the right questions, and ultimately, once you have a better understanding of how the mechanism works in humans, you can think much more specifically about the target population.”
Mechanisms were discussed throughout presentations, but mentions of the hallmarks overall were fewer and further between this year. Instead, the summit focused more on the felt pain points within specific high-impact, high-demand categories like women’s health, beauty-from-within, sleep, cognitive health and experiential energy.
The microbiome also featured as an enduring condition-agnostic healthspan target and one of the more compelling candidates for a systems-level approach to healthy aging.
Jens Walter, professor of ecology, food and the microbiome at University College Cork (UCC) in Ireland, non-causally connected nutritional interventions to microbiome signatures in the long-lived.
“There is very good evidence that the diet-microbiome interactions actually act throughout our entire life and then influences how we actually healthy age,” he said, referencing a foundational paper titled “Gut microbiota composition correlates with diet and health in the elderly” published in 2012 in the journal Nature by Paul O’Toole and colleagues at UCC.

Conclusions supported a relationship between diet, microbiota and health status and indicated a role for diet-driven microbiota alterations in varying rates of health decline upon aging.
Walter then worked through animal studies supporting plausibility and cited a study of UK Biobank data, which suggested that life expectancy can increase by up to 10 years following sustained shifts towards healthier diets in the UK.
“What these scientists also emphasized is that it’s in your 40s and 50s where you have to adopt this healthier eating pattern,” he added. “If you adopt a healthy eating pattern in your 70s, you can still probably have five-to-six years of longer healthspan and lifespan, but if you think about aging, you definitely have to start earlier in life.”
Avoiding the burden, getting started earlier in life
Delivering opening remarks at the summit, David Weinkove, Emeritus Chair of the British Society for Research on Aging, underscored the pressing nature of the growing global burden of population aging, driven by an unprecedented demographic shift marked by declining fertility rates and rising life expectancies.

“I’m going to start with a pretty bold statement and that is, I think our aging population is a bigger threat than climate change,” he said, adding that addressing this challenge requires a parallel shift away from disease treatment towards prevention, grounded in the recognition that aging itself is malleable.
Weinkove made the case that helping people stay healthy for longer offsets the pressures of rising living costs, strained healthcare systems and heightened societal tensions. He called for more longitudinal clinical trials, ideally involving healthy but aging individuals, and suggested that research funding challenges would benefit from a collaborative approach among industry, charities, government and universities.
Presenting research on how correcting fundamental micronutrient deficiencies could help prevent brain atrophy, Harry Jarrett, director of science and research at supplement brand Heights, echoed the importance of translating scientific findings—such as the VITACOG trial, which linked B vitamin supplementation to a reduction in brain atrophy—into political action.
“We do need government action, we need public policy action, we need more education for the public to really inform them of these hidden micronutrient deficiencies and what they could entail, but then also we need easily accessible interventions, supplementation to help individuals on a personal level correct these hidden micronutrient deficiencies and protect their brain whilst they age,” he said.
A morning of sessions dedicated to women’s healthspan offered a compelling case for the value of adopting a preventative approach, tracing a cumulative trajectory shaped by early-life programming, reproductive transitions, gradual muscle loss and the sharp drop in estrogen during menopause.
“If you have a poor diet or are overweight, then you’re not going to go through puberty and develop a healthy menstrual cycle and that can lead to poor fertility and an increased risk of PMOS,” said Preeti Jethwa, scientific committee member at Women in Nutraceuticals (WIN). “Then you go into pregnancy, and if you do not have the stores for your body mass or your bones, then your fetus will take everything, and you’re going to become even more deficient. And then, when you go into pre-menopause and menopause, you are already in poor metabolic health.”
She emphasized that nutrition is important throughout each of these life stages, albeit each with its specific needs.

Speaking to how products are marketed to life stages, Jenna Macciochi, director of science and innovation at wellness brand Ancient + Brave, rejected the growing use of fear as sales tactic—particularly by uncredentialed, commissioned influencers targeting women entering menopause.
“It’s a transition that humans have experienced for millennia,” she said. “There are ways of navigating it that can be helpful. There are challenges with modern life that make it more difficult, but we’re selling this as a medical problem to fix instead of perhaps looking at the broader things that a person might need to be supported. A climate of fear is commercially lucrative—customers become acclimatized to that, and that’s what they learn to expect.”
Instead, Ancient + Brave advocates for a new narrative—one that recognizes hormones as fundamental to whole-body health, not merely reproductive health, and acknowledges their influence across the key hormonal transitions that shape a woman’s healthspan.
Science apps and agentic advisors for real-world results
A preventative health approach inevitably requires a certain degree of faith in future health outcomes, but this year’s summit also surfaced a clear consumer preference for perceived benefits in the here and now that provide an immediate incentive to invest in habits that may support long-term healthspan.
“I think longevity is very aspirational, and even though people want to live longer and want to live healthier for longer, there is this kind of nearsighted element to everything, which is, ‘If I’m gonna’ spend my money on something, I wanna’ feel good,’” said industry consultant Thomas Beadnall during a closing takeaways panel.
Feeling good in this new dawn and day of healthspan also introduces an expectation of efficacy. To this end, a presentation by Amanda Rao, founder and CEO of contract research organization RDC Global, explored the pharmacokinetic mechanisms that allow bioactives to reach their intended target and deliver efficacy. A separate session on wearables, personalization and AI examined how population-wide technologies are expanding consumer ability to access and assess product benefits in real time and situation.
The application of these technologies is also extending toward more individualized nutrition insights. In a not-so-distant future, personalized AI operating as health agents within platform-centric business models may also be able to help consumers understand their nutritional needs by interpreting relevant blood test results, analyzing dietary patterns and lifestyle habits, identifying potential nutritional gaps, evaluating supplement ingredients and scientific evidence, and tracking changes over time.
Legacy supplement brand Thorne is already exploring this space with its AI-powered wellness chatbot, Taia. Trained on more than 40 years of the company’s clinical research, practitioner expertise and education content, the agent is designed to help consumers navigate an increasingly complex landscape of choices, trends and advice.
As supplementation moves beyond one-size-fits-all, there is also increased research interest in evaluating benefits at the individual level or within cohorts that share common characteristics. Here, decentralized clinical trials have emerged as a potential infrastructure for studying personalized supplementation in real-world conditions.
Recognized as one of this year’s Healthspan Innovator startups alongside postbiotic ingredient biotech company Kioga and cellular health-focused brand Longevity Life Sciences, Alethios presented the rapid expansion and adoption of its decentralized research platform since launch in late 2025.

Zeenia Framroze, CEO and founder of Alethios highlighted not only how remote, digitized studies are lowering the barriers to healthspan research but also how well they reflect the people they aim to help.
“Healthspan means something different to everyone, and research infrastructure has to reflect that,” she said. “Decentralized trials are actually uniquely well-suited to longevity research for those reasons. Having many more people involved in the development of research questions and healthspan is critical.”
Key benefits cited included lower cost, faster timelines, participant-friendly design, richer, more rigorous data, broader representation and wider access for researchers.
Participating in a subsequent panel on moving from data to decisions to personalized healthspan, Jeff Chen, CEO and co-founder of Radicle Science, noted the wider shift towards generating data that is more generalizable and predictive in the real world.
Launched in 2020 for the non-pharmaceutical space, the company’s decentralized “proof-as-a-service” research platform is currently being deployed in support of the GUT-FEELINGS study, backed by the U.S. Department of Health and Human Service’s Advanced Research Projects Agency for Health (ARPA-H). The 16-week, decentralized, randomized, double-blind, placebo-controlled trial includes 20 arms and over 6,000 U.S. adults experiencing mild-to-moderate anxiety.
“You have to scale up on the sample size, you have to get more power, and then you have to get diversity in, and you just simply can’t get that diversity and representation at a site,” he said. “Even if it’s not the diversity of the individuals represented, it’s the diversity of the environments represented—that real world lived experience that is going to translate.”
Nutra Healthspan Summit 2027
The Nutra Healthspan Summit 2027 is scheduled to take place at the Novotel London West from December 9 to 10, 2027.




